Noked Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Noked Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$14.5K	Buy	182,582 +74,882	+70%	+$6.31M	1.53%	12
2022 Q2	$8M	Buy	+107,700	New	+$8.08M	1.84%	14

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Noked Capital's XBI Position: Q3 2022 in Review

Noked Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 70% in Q3 2022, buying an estimated $6.31M and bringing the position to 182,582 shares worth $14.5K. The position accounts for 1.53% of the portfolio, ranked #12.

Noked Capital first reported a position in XBI in Q2 2022 and has held it in 2 quarters since. The position peaked at $8M in Q2 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Noked Capital held 182,582 shares of State Street SPDR S&P Biotech ETF worth $14.5K as of Q3 2022.
Noked Capital bought 74,882 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $6.31M.
State Street SPDR S&P Biotech ETF made up 1.53% of Noked Capital's portfolio in Q3 2022, its #12 holding.
Noked Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 2 quarters since.
Noked Capital's State Street SPDR S&P Biotech ETF position peaked at $8M in Q2 2022.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Noked Capital's 13F filing for Q3 2022, filed 14 Nov 2022.